Skin-specific promoters for genetic immunisation by DNA electroporation

Vaccine

Volumn 27, Issue 32, 2009, Pages 4272-4277

  Vandermeulen, Gaëlle ^a   Richiardi, Hervé ^a   Escriou, Virginie ^b   Ni, Jing ^c   Fournier, Philippe ^c   Schirrmacher, Volker ^c   Scherman, Daniel ^b   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSERM   (France)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

DNA vaccine; Electroporation; Electrotransfer; Vaccination

Indexed keywords

CYTOKERATIN 14; DNA VACCINE; FASCIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; LUCIFERASE; PLASMID DNA;

ANIMAL EXPERIMENT; ARTICLE; BASEMENT MEMBRANE; CELL TYPE; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; DENDRITIC CELL; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; DRUG SAFETY; ELECTROPORATION; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC IMMUNIZATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; KERATINOCYTE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN; TISSUE SPECIFICITY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIBODIES; CYTOKINES; ELECTROPORATION; FEMALE; GENE EXPRESSION; GENES, REPORTER; LUCIFERASES; LYMPHOCYTES; MICE; MICE, INBRED BALB C; PLASMIDS; PROMOTER REGIONS, GENETIC; SKIN; VACCINES, DNA;

EID: 67649484348     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.022     Document Type: Article

References (24)

1. Pavselj N., and Preat V. DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse. J Control Release 106 September 2 (3) (2005) 407-415
2. Andre F., Gehl J., Sersa G., et al. Efficiency of high and low voltage pulse combinations for gene electrotransfer in muscle, liver, tumor and skin. Hum Gene Ther 19 August 21 (11) (2008) 1233-1248
3. Vandermeulen G., Staes E., Vanderhaeghen M.L., Bureau M.F., Scherman D., and Preat V. Optimisation of intradermal DNA electrotransfer for immunisation. J Control Release 124 December 4 (1-2) (2007) 81-87
4. Cui Z., Dierling A., and Foldvari M. Non-invasive immunization on the skin using DNA vaccine. Curr Drug Deliv 3 January (1) (2006) 29-35
5. Romani N., Ebner S., Tripp C.H., Flacher V., Koch F., and Stoitzner P. Epidermal Langerhans cells-changing views on their function in vivo. Immunol Lett 106 August 15 (2) (2006) 119-125
6. Loser K., and Beissert S. Dendritic cells and T cells in the regulation of cutaneous immunity. Adv Dermatol 23 (2007) 307-333
7. Debenedictis C., Joubeh S., Zhang G., Barria M., and Ghohestani R.F. Immune functions of the skin. Clin Dermatol 19 September (5) (2001) 573-585
8. Partidos C.D., and Muller S. Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy. Cell Mol Life Sci 62 July (13) (2005) 1418-1424
9. Rice J., Ottensmeier C.H., and Stevenson F.K. DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 8 February (2) (2008) 108-120
10. Lin M.T., Wang F., Uitto J., and Yoon K. Differential expression of tissue-specific promoters by gene gun. Br J Dermatol 144 January (1) (2001) 34-39
11. Glenting J., and Wessels S. Ensuring safety of DNA vaccines. Microb Cell Fact 4 September 6 (2005) 26
12. Forg P., von H.P., Dalemans W., and Schirrmacher V. Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther 5 June (6) (1998) 789-797
13. Staggers W.R., Paterson A.J., and Kudlow J.E. Sequence of the functional human keratin K14 promoter. Gene 153 February 14 (2) (1995) 297-298
14. Ross R., Sudowe S., Beisner J., et al. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin. Gene Ther 10 June (12) (2003) 1035-1040
15. Sudowe S., Ludwig-Portugall I., Montermann E., Ross R., and Reske-Kunz A.B. Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responses. Mol Ther 8 October (4) (2003) 567-575
16. Bloquel C., Trollet C., Pradines E., Seguin J., Scherman D., and Bureau M.F. Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee. BMC Biotechnol 6 (2006) 16
17. Cho J.H., Youn J.W., and Sung Y.C. Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization. J Immunol 167 November 15 (10) (2001) 5549-5557
18. Hon H., Oran A., Brocker T., and Jacob J. B lymphocytes participate in cross-presentation of antigen following gene gun vaccination. J Immunol 174 May 1 (9) (2005) 5233-5242
19. Lauterbach H., Gruber A., Ried C., Cheminay C., and Brocker T. Insufficient APC capacities of dendritic cells in gene gun-mediated DNA vaccination. J Immunol 176 April 15 (8) (2006) 4600-4607
20. Jonuleit H., Schmitt E., Schuler G., Knop J., and Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 November 6 (9) (2000) 1213-1222
21. Feltquate D.M., Heaney S., Webster R.G., and Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158 March 1 (5) (1997) 2278-2284
22. McCluskie M.J., Brazolot Millan C.L., Gramzinski R.A., et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 5 May (5) (1999) 287-300
23. Gronevik E., Mathiesen I., and Lomo T. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses. J Gene Med 7 September (9) (2005) 1246-1254
24. Wang S., Zhang C., Zhang L., Li J., Huang Z., and Lu S. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 26 April 16 (17) (2008) 2100-2110